| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-07 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-06 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-05 |